It is known that IDH1/2 mutations are ubiquitous in IDH-mutant astrocytomas, which means that all tumor cells present a heterozygous mutation of IDH1 or IDH2 and retain a wild-type allele, necessary for tumor cell survival. Here, IDH2 is linked to neoplasm.